Particle News: Latest AstraZeneca news

CDC Panel Recommends Merck’s Enflonsia Monoclonal Antibody for Babies

Approval by Health Secretary Robert F. Kennedy Jr. is the final step before the FDA-cleared antibody becomes available to infants.

AstraZeneca Cancels £450m UK Vaccine Plant Investment

GSK Proposes Doubling CEO Emma Walmsley’s Pay to $27 Million

UK Finalizes £1bn BioNTech Deal to Advance mRNA Cancer Vaccines and AI Research

AstraZeneca Deepens China Pact With $5.2 Billion CSPC Research Collaboration

NICE Approves Capivasertib for NHS Use in Advanced Breast Cancer Treatment

AstraZeneca Announces $2.5 Billion Beijing R&D Hub to Bolster China Presence

Engineered E. Coli Converts Plastic Waste to Paracetamol

AstraZeneca Acquires Belgian Biotech EsoBiotec in $1 Billion Deal

Pharma CEOs Urge EU to Reform Pricing Policies as U.S. Investments Surge

Tempus AI Surpasses Q1 Expectations, Raises 2025 Revenue Guidance

IonQ to Acquire Oxford Ionics for $1.075 Billion to Expand Quantum Capabilities

AstraZeneca Reports Strong 2024 Results While Facing China Tax Probe

FDA Approves Merck’s Enflonsia Monoclonal Antibody for Infant RSV Prevention

London IPO Fundraising Falls to 30-Year Low as Issuers Delay or Shift Listings

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

Nvidia Partners with Swedish Consortium to Build Country’s Biggest Enterprise AI Supercomputer

AstraZeneca Cancels £450m UK Vaccine Plant Expansion Over Funding Dispute